De Novellis, D.; Fontana, R.; Carobene, A.; Serio, B.; Ferrara, I.; Martorelli, M.C.; Mettivier, L.; Guariglia, R.; Luponio, S.; Ruggiero, I.;
et al. Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study. Biomedicines 2022, 10, 1657.
https://doi.org/10.3390/biomedicines10071657
AMA Style
De Novellis D, Fontana R, Carobene A, Serio B, Ferrara I, Martorelli MC, Mettivier L, Guariglia R, Luponio S, Ruggiero I,
et al. Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study. Biomedicines. 2022; 10(7):1657.
https://doi.org/10.3390/biomedicines10071657
Chicago/Turabian Style
De Novellis, Danilo, Raffaele Fontana, Angela Carobene, Bianca Serio, Idalucia Ferrara, Maria Carmen Martorelli, Laura Mettivier, Roberto Guariglia, Serena Luponio, Immacolata Ruggiero,
and et al. 2022. "Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study" Biomedicines 10, no. 7: 1657.
https://doi.org/10.3390/biomedicines10071657
APA Style
De Novellis, D., Fontana, R., Carobene, A., Serio, B., Ferrara, I., Martorelli, M. C., Mettivier, L., Guariglia, R., Luponio, S., Ruggiero, I., D’Addona, M., Di Leo, T., Giudice, V., & Selleri, C.
(2022). Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study. Biomedicines, 10(7), 1657.
https://doi.org/10.3390/biomedicines10071657
